Health technology assessment (HTA) is a multidisciplinary process that summarises the available information about the medical, social, economic, organisational, ethical and medico-legal issues related to the development, diffusion and use of a health technology.
In Ireland, the Health Information and Quality Authority (HIQA) is mandated under the Health Act 2007 to carry out HTA and develop guidelines for HTA preparation across the Irish health system (this includes pharmaceuticals, devices, diagnostics, procedures, care pathways and public health activities). For more information on HIQA’s role, click here.
The National Centre for Pharmacoeconomics (NCPE) is commissioned by the Health Service Executive to perform HTAs on pharmaceutical products, in particular on whether new treatments should be made available at the State’s expense. When this assessment is complete, the NCPE makes a recommendation to the HSE. The HSE then examines all the evidence which may be relevant for the decision and the final decision on reimbursement is made by the HSE. NCPE also work with other HTA bodies such as HIQA as well as engaging in research with academic units. For more on the NCPE, click here.